- Home
- EBS vs CEVA Comparison
EBS vs CEVA Comparison
Compare EBS & CEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EBS | CEVA |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.6M | 573.9M |
| IPO Year | 2006 | 2002 |
Fundamental Metrics
Financial Performance| Metric | EBS | CEVA |
|---|---|---|
| Price | $10.78 | $19.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $15.00 | ★ $33.25 |
| AVG Volume (30 Days) | ★ 522.0K | 367.0K |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.76 | 27.45 |
| EPS | ★ 1.89 | N/A |
| Revenue | ★ $1,043,600,000.00 | $87,507,000.00 |
| Revenue This Year | N/A | $14.97 |
| Revenue Next Year | $15.21 | $12.74 |
| P/E Ratio | $5.74 | ★ N/A |
| Revenue Growth | N/A | ★ 20.45 |
| 52 Week Low | $4.02 | $18.23 |
| 52 Week High | $14.06 | $34.68 |
Technical Indicators
Market Signals| Indicator | EBS | CEVA |
|---|---|---|
| Relative Strength Index (RSI) | 45.93 | 38.90 |
| Support Level | $10.50 | $18.27 |
| Resistance Level | $12.60 | $24.01 |
| Average True Range (ATR) | 0.53 | 1.15 |
| MACD | 0.02 | -0.32 |
| Stochastic Oscillator | 46.21 | 19.76 |
Price Performance
Historical ComparisonAbout EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About CEVA CEVA Inc.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.